APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin API

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Selected research

Industry Growth & Trends

Global Insulin API Industry Growth and Trends Forecast to 2032

2 January 2026103 pages

Choose your research edition.

Industry ResearchInsulin API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin API Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Insulin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Read the full market overview

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

Report Scope

This report provides a structured, data-driven view of the global Insulin API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin API market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin API Market by Company

Novo Nordisk

Sanofi-Aventis

Eli Lilly

Tonghua Dongbao

Ganlee

United Laboratory

Biocon

Amphastar

Wockhardt

Julphar Diabetes

Torrent Pharma

Insulin API Segment by Type

Regular Human Insulin

Insulin Analogue

Insulin API Segment by Application

Fast-Acting

Premix

Long-Acting

Insulin API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Regular Human Insulin Table 2. Major Company of Insulin Analogue Table 3. Global Insulin API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Insulin API Sales by Type (2021-2026) & (Kg) Table 5. Global Insulin API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Insulin API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Insulin API Sales Market Share in Value by Type (2021-2026) Table 8. Global Insulin API Price by Type (2021-2026) & (K US$/Kg) Table 9. Global Insulin API Sales by Type (2027-2032) & (Kg) Table 10. Global Insulin API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Insulin API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Insulin API Sales Market Share in Value by Type (2027-2032) Table 13. Global Insulin API Price by Type (2027-2032) & (K US$/Kg) Table 14. North America Insulin API Sales by Type (2021-2026) & (Kg) Table 15. North America Insulin API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Insulin API Sales by Type (2021-2026) & (Kg) Table 17. Europe Insulin API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Insulin API Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Insulin API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Insulin API Sales by Type (2021-2026) & (Kg) Table 21. Latin America Insulin API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Insulin API Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Insulin API Sales by Type (2021-2026) & (US$ Million) Table 24. Insulin API Industry Trends Table 25. Insulin API Industry Drivers Table 26. Insulin API Industry Opportunities and Challenges Table 27. Insulin API Industry Restraints Table 28. Global Insulin API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Insulin API Revenue Market Share by Company (2021-2026) Table 30. Global Insulin API Sales by Company (2021-2026) & (Kg) Table 31. Global Insulin API Sales Share by Company (2021-2026) Table 32. Global Insulin API Market Price by Company (2021-2026) & (K US$/Kg) Table 33. Global Insulin API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Insulin API Major Company Production Sites and Headquarters Table 35. Global Insulin API Company, Product Type & Application Table 36. Global Insulin API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Insulin API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Insulin API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Insulin API Sales by Region (2021-2026) & (Kg) Table 41. Global Insulin API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Insulin API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Insulin API Sales Market Share in Value by Region (2021-2026) Table 44. Global Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 45. Global Insulin API Sales by Region (2027-2032) & (Kg) Table 46. Global Insulin API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Insulin API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Insulin API Sales Market Share in Value by Region (2027-2032) Table 49. Global Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2027-2032) Table 50. Global Insulin API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Insulin API Sales by Application (2021-2026) & (Kg) Table 52. Global Insulin API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Insulin API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Insulin API Sales Market Share in Value by Application (2021-2026) Table 55. Global Insulin API Price by Application (2021-2026) & (K US$/Kg) Table 56. Global Insulin API Sales by Application (2027-2032) & (Kg) Table 57. Global Insulin API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Insulin API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Insulin API Sales Market Share in Value by Application (2027-2032) Table 60. Global Insulin API Price by Application (2027-2032) & (K US$/Kg) Table 61. North America Insulin API Sales by Application (2021-2026) & (Kg) Table 62. North America Insulin API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Insulin API Sales by Application (2021-2026) & (Kg) Table 64. Europe Insulin API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Insulin API Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Insulin API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Insulin API Sales by Application (2021-2026) & (Kg) Table 68. Latin America Insulin API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Insulin API Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Insulin API Sales by Application (2021-2026) & (US$ Million) Table 71. Novo Nordisk Company Information Table 72. Novo Nordisk Business Overview Table 73. Novo Nordisk Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 74. Novo Nordisk Insulin API Product Portfolio Table 75. Novo Nordisk Recent Development Table 76. Sanofi-Aventis Company Information Table 77. Sanofi-Aventis Business Overview Table 78. Sanofi-Aventis Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 79. Sanofi-Aventis Insulin API Product Portfolio Table 80. Sanofi-Aventis Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 84. Eli Lilly Insulin API Product Portfolio Table 85. Eli Lilly Recent Development Table 86. Tonghua Dongbao Company Information Table 87. Tonghua Dongbao Business Overview Table 88. Tonghua Dongbao Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 89. Tonghua Dongbao Insulin API Product Portfolio Table 90. Tonghua Dongbao Recent Development Table 91. Ganlee Company Information Table 92. Ganlee Business Overview Table 93. Ganlee Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 94. Ganlee Insulin API Product Portfolio Table 95. Ganlee Recent Development Table 96. United Laboratory Company Information Table 97. United Laboratory Business Overview Table 98. United Laboratory Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 99. United Laboratory Insulin API Product Portfolio Table 100. United Laboratory Recent Development Table 101. Biocon Company Information Table 102. Biocon Business Overview Table 103. Biocon Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 104. Biocon Insulin API Product Portfolio Table 105. Biocon Recent Development Table 106. Amphastar Company Information Table 107. Amphastar Business Overview Table 108. Amphastar Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 109. Amphastar Insulin API Product Portfolio Table 110. Amphastar Recent Development Table 111. Wockhardt Company Information Table 112. Wockhardt Business Overview Table 113. Wockhardt Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 114. Wockhardt Insulin API Product Portfolio Table 115. Wockhardt Recent Development Table 116. Julphar Diabetes Company Information Table 117. Julphar Diabetes Business Overview Table 118. Julphar Diabetes Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 119. Julphar Diabetes Insulin API Product Portfolio Table 120. Julphar Diabetes Recent Development Table 121. Torrent Pharma Company Information Table 122. Torrent Pharma Business Overview Table 123. Torrent Pharma Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 124. Torrent Pharma Insulin API Product Portfolio Table 125. Torrent Pharma Recent Development Table 126. North America Insulin API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 127. North America Insulin API Sales by Country (2021-2026) & (Kg) Table 128. North America Insulin API Sales Market Share by Country (2021-2026) Table 129. North America Insulin API Sales Forecast by Country (2027-2032) & (Kg) Table 130. North America Insulin API Sales Market Share Forecast by Country (2027-2032) Table 131. North America Insulin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Insulin API Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Insulin API Market Share by Country (2021-2026) Table 134. North America Insulin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Insulin API Market Share Forecast by Country (2027-2032) Table 136. Europe Insulin API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 137. Europe Insulin API Sales by Country (2021-2026) & (Kg) Table 138. Europe Insulin API Sales Market Share by Country (2021-2026) Table 139. Europe Insulin API Sales Forecast by Country (2027-2032) & (Kg) Table 140. Europe Insulin API Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Insulin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Insulin API Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Insulin API Market Share by Country (2021-2026) Table 144. Europe Insulin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Insulin API Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Insulin API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Insulin API Sales by Country (2021-2026) & (Kg) Table 148. Asia-Pacific Insulin API Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Insulin API Sales Forecast by Country (2027-2032) & (Kg) Table 150. Asia-Pacific Insulin API Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Insulin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Insulin API Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Insulin API Market Share by Country (2021-2026) Table 154. Asia-Pacific Insulin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Insulin API Market Share Forecast by Country (2027-2032) Table 156. Latin America Insulin API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. Latin America Insulin API Sales by Country (2021-2026) & (Kg) Table 158. Latin America Insulin API Sales Market Share by Country (2021-2026) Table 159. Latin America Insulin API Sales Forecast by Country (2027-2032) & (Kg) Table 160. Latin America Insulin API Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Insulin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Insulin API Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Insulin API Market Share by Country (2021-2026) Table 164. Latin America Insulin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Insulin API Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Insulin API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Insulin API Sales by Country (2021-2026) & (Kg) Table 168. Middle East and Africa Insulin API Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Insulin API Sales Forecast by Country (2027-2032) & (Kg) Table 170. Middle East and Africa Insulin API Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Insulin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Insulin API Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Insulin API Market Share by Country (2021-2026) Table 174. Middle East and Africa Insulin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Insulin API Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Insulin API Distributors List Table 179. Insulin API Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Insulin API Image Figure 2. Global Insulin API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin API Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin API Sales (2021-2032) & (Kg) Figure 5. Regular Human Insulin Image Figure 6. Global Regular Human Insulin Sales YoY Growth (2021-2032) & (Kg) Figure 7. Insulin Analogue Image Figure 8. Global Insulin Analogue Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Insulin API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Insulin API Market Share by Type 2025 VS 2032 Figure 11. North America Insulin API Sales Market Share in Volume by Type in 2025 Figure 12. North America Insulin API Sales Market Share in Value by Type in 2025 Figure 13. Europe Insulin API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Insulin API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Insulin API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Insulin API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Insulin API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Insulin API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Insulin API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Insulin API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Insulin API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Fast-Acting Image Figure 24. Global Fast-Acting Sales YoY Growth (2021-2032) & (Kg) Figure 25. Premix Image Figure 26. Global Premix Sales YoY Growth (2021-2032) & (Kg) Figure 27. Long-Acting Image Figure 28. Global Long-Acting Sales YoY Growth (2021-2032) & (Kg) Figure 29. Global Insulin API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Insulin API Market Share by Application 2025 VS 2032 Figure 31. North America Insulin API Sales Market Share in Volume by Application in 2025 Figure 32. North America Insulin API Sales Market Share in Value by Application in 2025 Figure 33. Europe Insulin API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Insulin API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Insulin API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Insulin API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Insulin API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Insulin API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Insulin API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Insulin API Sales Market Share in Value by Application in 2025 Figure 41. North America Insulin API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 42. North America Insulin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Insulin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Insulin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Insulin API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. Europe Insulin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Insulin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Insulin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Insulin API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Asia-Pacific Insulin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Insulin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Insulin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Insulin API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Latin America Insulin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Insulin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Insulin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Insulin API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Middle East and Africa Insulin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Insulin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Insulin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Insulin API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Insulin API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Regular Human Insulin
  • Insulin Analogue
Applications
  • Fast-Acting
  • Premix
  • Long-Acting
Companies covered
  • Novo Nordisk
  • Sanofi-Aventis
  • Eli Lilly
  • Tonghua Dongbao
  • Ganlee
  • United Laboratory
  • Biocon
  • Amphastar
  • Wockhardt
  • Julphar Diabetes
  • Torrent Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin API Market by Type
  6. 1.3.1 Regular Human Insulin
  7. 1.3.2 Insulin Analogue
  8. 1.4 Global Insulin API Market Size by Type
  9. 1.4.1 Global Insulin API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Insulin API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Insulin API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Insulin API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Insulin API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Insulin API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Insulin API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Insulin API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin API Industry Trends
  2. 2.2 Insulin API Industry Drivers
  3. 2.3 Insulin API Industry Opportunities and Challenges
  4. 2.4 Insulin API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin API Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin API Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin API Price (2021-2026)
  4. 3.4 Global Insulin API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin API Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin API Company, Product Type & Application
  7. 3.7 Global Insulin API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin API Tier 1, Tier 2, and Tier 3
4 Insulin API Regional Status and Outlook
  1. 4.1 Global Insulin API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin API Historic Market Size by Region
  3. 4.2.1 Global Insulin API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin API Forecasted Market Size by Region
  7. 4.3.1 Global Insulin API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin API by Application
  1. 5.1 Insulin API Market by Application
  2. 5.1.1 Fast-Acting
  3. 5.1.2 Premix
  4. 5.1.3 Long-Acting
  5. 5.2 Global Insulin API Market Size by Application
  6. 5.2.1 Global Insulin API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Insulin API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Insulin API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Insulin API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Insulin API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Insulin API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Insulin API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Insulin API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novo Nordisk
  2. 6.1.1 Novo Nordisk Company Information
  3. 6.1.2 Novo Nordisk Business Overview
  4. 6.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novo Nordisk Insulin API Product Portfolio
  6. 6.1.5 Novo Nordisk Recent Developments
  7. 6.2 Sanofi-Aventis
  8. 6.2.1 Sanofi-Aventis Company Information
  9. 6.2.2 Sanofi-Aventis Business Overview
  10. 6.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi-Aventis Insulin API Product Portfolio
  12. 6.2.5 Sanofi-Aventis Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Insulin API Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Tonghua Dongbao
  20. 6.4.1 Tonghua Dongbao Company Information
  21. 6.4.2 Tonghua Dongbao Business Overview
  22. 6.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tonghua Dongbao Insulin API Product Portfolio
  24. 6.4.5 Tonghua Dongbao Recent Developments
  25. 6.5 Ganlee
  26. 6.5.1 Ganlee Company Information
  27. 6.5.2 Ganlee Business Overview
  28. 6.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ganlee Insulin API Product Portfolio
  30. 6.5.5 Ganlee Recent Developments
  31. 6.6 United Laboratory
  32. 6.6.1 United Laboratory Company Information
  33. 6.6.2 United Laboratory Business Overview
  34. 6.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 United Laboratory Insulin API Product Portfolio
  36. 6.6.5 United Laboratory Recent Developments
  37. 6.7 Biocon
  38. 6.7.1 Biocon Company Information
  39. 6.7.2 Biocon Business Overview
  40. 6.7.3 Biocon Insulin API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biocon Insulin API Product Portfolio
  42. 6.7.5 Biocon Recent Developments
  43. 6.8 Amphastar
  44. 6.8.1 Amphastar Company Information
  45. 6.8.2 Amphastar Business Overview
  46. 6.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amphastar Insulin API Product Portfolio
  48. 6.8.5 Amphastar Recent Developments
  49. 6.9 Wockhardt
  50. 6.9.1 Wockhardt Company Information
  51. 6.9.2 Wockhardt Business Overview
  52. 6.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Wockhardt Insulin API Product Portfolio
  54. 6.9.5 Wockhardt Recent Developments
  55. 6.10 Julphar Diabetes
  56. 6.10.1 Julphar Diabetes Company Information
  57. 6.10.2 Julphar Diabetes Business Overview
  58. 6.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Julphar Diabetes Insulin API Product Portfolio
  60. 6.10.5 Julphar Diabetes Recent Developments
  61. 6.11 Torrent Pharma
  62. 6.11.1 Torrent Pharma Company Information
  63. 6.11.2 Torrent Pharma Business Overview
  64. 6.11.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Torrent Pharma Insulin API Product Portfolio
  66. 6.11.5 Torrent Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Insulin API Sales by Country
  2. 7.1.1 North America Insulin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin API Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin API Market Size by Country
  6. 7.2.1 North America Insulin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin API Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin API Sales by Country
  2. 8.1.1 Europe Insulin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin API Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin API Market Size by Country
  6. 8.2.1 Europe Insulin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin API Sales by Country
  2. 9.1.1 Asia-Pacific Insulin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin API Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin API Sales by Country
  2. 10.1.1 South America Insulin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin API Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin API Market Size by Country
  6. 10.2.1 South America Insulin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin API Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin API Sales by Country
  2. 11.1.1 Middle East and Africa Insulin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin API Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin API Value Chain Analysis
  2. 12.1.1 Insulin API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin API Production Mode & Process
  7. 12.2 Insulin API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin API Distributors
  10. 12.2.3 Insulin API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst